POCKET PROTEIN/E2F REGULATES LUNG CELL DIFFERENTIATION
口袋蛋白/E2F 调节肺细胞分化
基本信息
- 批准号:6242151
- 负责人:
- 金额:$ 31.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至 1998-06-30
- 项目状态:已结题
- 来源:
- 关键词:cell differentiation cell line developmental genetics embryo /fetus tissue /cell culture gene expression genetic regulation genetic transcription genetically modified animals laboratory mouse lung alveolus lysozyme pulmonary surfactants respiratory epithelium retinoblastoma protein transcription factor
项目摘要
This project has as its goal an exploration of the roles that the
retinoblastoma family of proteins (pRb, p107, p130), the E2F
family of proteins (E2F-1 to E2F-5) and the CBP/p300 proteins
play in the regulation of alveolar epithelial cell differentiation.
The pRb/E2F proteins have been intensively studied because of
their critical role in cell cycle regulation. However, increasing
evidence from a number of systems suggests that they also play
important roles in cell differentiation. CBP/p300 have recently
been described as co-activators of gene transcription and appear to
serve as mediators of multisignal transduction pathways. Both
pRb and CBP/p300 complex with a number of factors that have
the potential to influence lung cell gene expression. These include
for pRb, the glucocorticoid response element and the transcription
factor C/EBP; for CPB/p300, the cAMP response element, AP-1
and a number of nuclear hormone receptors. The surfactant
proteins, T1 alpha and GGT all contain putative binding sites for
these elements. We therefore plan to: 1) define the timing and
sites of expression of the pRb and E2F gene families in normal
and pRb family null mutant mice; 2) examine the role that the
E2F-5 gene we have cloned from the lung plays in regulating lung
cell proliferation and differentiation; and 3) determine whether
CBP/p300 plays an important role in regulating expression of lung
epithelial cells. Preliminary studies provide data that supports the
rationale for each of this aims. The studies will be carried out
using cell lines, in vitro embryonic lung culture systems and
transgenic mice. We will focus on how pRb affects expression of
the lat alveolar genes, SP-A, SP-D and lysozyme and how
CBP/p300 regulates expression of these and other genes being
studied in the PPG. The studies we propose continue the goals set
forth in the first five years of this Project, which were to explore
the relationship between lung epithelial cell proliferation an
differentiation, but focus our studies on specific mechanisms.
该项目的目标是探索
视网膜母细胞瘤蛋白家族(pRb,p107,p130),E2 F
蛋白质家族(E2 F-1至E2 F-5)和CBP/p300蛋白质
在调节肺泡上皮细胞分化中发挥作用。
pRb/E2 F蛋白已被深入研究,因为
它们在细胞周期调节中的关键作用。 然而,日益
许多系统的证据表明,
在细胞分化中的重要作用。 CBP/P300最近
被描述为基因转录的共激活因子,
作为多信号转导通路的介质。 两
pRb和CBP/p300复合物与许多因素,
影响肺细胞基因表达的潜力。 这些包括
对于pRb,糖皮质激素反应元件和转录,
因子C/EBP; CPB/p300,cAMP反应元件,AP-1
和一些核激素受体。 表面活性剂
蛋白质,T1 α和GGT都含有推定的结合位点,
这些元素。 因此,我们计划:1)确定时间,
pRb和E2 F基因家族在正常人中的表达位点
和pRb家族无效突变小鼠; 2)检查
我们从肺中克隆的E2 F-5基因在调节肺功能中起着重要作用
细胞增殖和分化;以及3)确定是否
CBP/p300在肺组织中的表达调控中起重要作用
上皮细胞 初步研究提供的数据支持
每个目标的基本原理。 这些研究将在
使用细胞系、体外胚胎肺培养系统和
转基因小鼠我们将重点关注pRb如何影响
最新肺泡基因,SP-A,SP-D和溶菌酶,以及如何
CBP/p300调节这些和其他基因的表达,
研究了PPG。 我们建议的研究继续了既定的目标
在这个项目的前五年,我们将探索
肺上皮细胞增殖与
分化,但我们的研究集中在具体的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jerome S Brody其他文献
Jerome S Brody的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jerome S Brody', 18)}}的其他基金
Field of Injury Based Biomarkers for Lung Cancer
基于损伤的肺癌生物标志物领域
- 批准号:
7748114 - 财政年份:2009
- 资助金额:
$ 31.65万 - 项目类别:
POCKET PROTEIN/E2F REGULATES LUNG CELL DIFFERENTIATION
口袋蛋白/E2F 调节肺细胞分化
- 批准号:
6501912 - 财政年份:2001
- 资助金额:
$ 31.65万 - 项目类别:
POCKET PROTEIN/E2F REGULATES LUNG CELL DIFFERENTIATION
口袋蛋白/E2F 调节肺细胞分化
- 批准号:
6324747 - 财政年份:2000
- 资助金额:
$ 31.65万 - 项目类别:
POCKET PROTEIN/E2F REGULATES LUNG CELL DIFFERENTIATION
口袋蛋白/E2F 调节肺细胞分化
- 批准号:
6110104 - 财政年份:1999
- 资助金额:
$ 31.65万 - 项目类别:
POCKET PROTEIN/E2F REGULATES LUNG CELL DIFFERENTIATION
口袋蛋白/E2F 调节肺细胞分化
- 批准号:
6272904 - 财政年份:1998
- 资助金额:
$ 31.65万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL CELL DIFFERENTIATION
肺泡上皮细胞分化的调节
- 批准号:
2223356 - 财政年份:1992
- 资助金额:
$ 31.65万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL CELL DIFFERENTIATION
肺泡上皮细胞分化的调节
- 批准号:
2223359 - 财政年份:1992
- 资助金额:
$ 31.65万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL CELL DIFFERENTIATION
肺泡上皮细胞分化的调节
- 批准号:
3098866 - 财政年份:1992
- 资助金额:
$ 31.65万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 31.65万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 31.65万 - 项目类别: